Ocular and cutaneous effects of chronic phenothiazine therapy
Bond, W.S.; Yee, G.C.
American Journal of Hospital Pharmacy 37(1): 74-78
1980
ISSN/ISBN: 0002-9289 PMID: 6102438 Document Number: 156226
Document emailed within 1 workday
Related Documents
Cummings, P.; Lidahl, L.L. 1985: Ocular change and phenothiazine therapy American Family Physician 31(5): 23Caffery, B.E.; Josephson, J.E. 1988: Ocular side effects of isotretinoin therapy Journal of the American Optometric Association 59(3): 221-224
Debnath, S.C.; Abomelha, M.S.; Jawdat, M.; Chang, R.; Al-Khader, A.A. 1987: Ocular side effects of systemic steroid therapy in renal transplant patients Annals of Ophthalmology 19(11): 435-437
Creel, N.; Werth, V. 2005: Rhabdomyolysis associated with quinacrine therapy in a patient with chronic cutaneous lupus erythematosus Journal of Drugs in Dermatology: Jdd 4(2): 225-227
Chang, L.W.; Liranzo, M.; Bergfeld, W.F. 1995: Cutaneous side effects associated with interferon-alpha therapy: a review Cutis 56(3): 144
Singh, K.P. 1970: Some cardiovascular effects of 10-n substituted phenothiazine derivatives Indian Journal of Medical Research 58(3): 367-373
Hesse, R.J. 1979: Anterior lens opacities in prolonged phenothiazine therapy Annals of Ophthalmology 11(8): 1212
Bossert, J.; Mathis, C. 1976: Effects of fat excipients and antioxidants on conservation of suppositories containing phenothiazine derivatives Journal de Pharmacie de Belgique 31(4): 381-396
Zetin, M. 1979: Toxic psychosis induced by phenothiazine administration in patients with chronic renal failure Clinical Nephrology 12(2): 95-96
McAllister, C.J.; Scowden, E.B.; Stone, W.J. 1978: Toxic psychosis induced by phenothiazine administration in patients with chronic renal failure Clinical Nephrology 10(5): 191-195
Dölle, W.; Daiss, W. 1988: Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects Verhandlungen der Deutschen Gesellschaft für Innere Medizin 94: 184-191
Van der Vleuten, C.J.; Gerritsen, M.J.; De Jong, E.M.; Elbers, M.; De Jongh, G.J.; van de Kerkhof, P.C. 1996: A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris Acta Dermato-Venereologica 76(5): 387-391
Kraemer, K.H.; Lee, M.M.; Scotto, J. 1987: Xeroderma pigmentosum. Cutaneous, ocular, and neurologic abnormalities in 830 published cases Archives of Dermatology 123(2): 241-250
Touati, G.; Ruiz, J.C.; Porquet, D.; Kindermans, C.; Prieur, A.M.; Czernichow, P. 2000: Effects on bone metabolism of one year recombinant human growth hormone administration to children with juvenile chronic arthritis undergoing chronic steroid therapy Journal of Rheumatology 27(5): 1287-1293
Valentin, J.; Léonhardt, D.; Perrin, M. 1988: Prevention of venous thromboses and cutaneous necroses using physical methods and pressure therapy in the surgery of chronic venous insufficiency of the lower limbs Phlebologie 41(3): 690-696
Ortonne, J.P.; Floret, D.; Coiffet, J.; Cottin, X. 1978: Ocular and cutaneous melanosis associated with the Sturge-Weber syndrome: clinical, histological, and ultrastructural studies of one case Annales de Dermatologie et de Venereologie 105(12): 1019-1031
Lo Sicco, K.; Latkowski, J-Ann. 2015: Therapeutic Update: Update on Cutaneous and Systemic Therapy for Primary Cutaneous T Cell Lymphoma, Mycosis Fungoides Journal of Drugs in Dermatology: Jdd 14(12): 1381-1383
Gupta, A.K. 1988: 'Perming' effects associated with chronic valproate therapy British Journal of Clinical Practice 42(2): 75-77
Bolton, L. 2015: Hyperbaric Oxygen Therapy Effects on Chronic Wounds Wounds: a Compendium of Clinical Research and Practice 27(12): 354-355
Arase, Y. 2006: Side effects of interferon therapy for chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 64(7): 1363-1367